| Title |
Abiraterone- und Cabazitaxel-Härtefallprogramm
|
|---|---|
| Published in |
Die Urologie, February 2012
|
| DOI | 10.1007/s00120-012-2804-y |
| Pubmed ID | |
| Authors |
M.M. Heck, M. Höppner, T. Horn, M. Thalgott, J.E. Gschwend, M. Retz |
| Abstract |
First clinical experiences with abiraterone and cabazitaxel for the treatment of metastatic castration-resistant prostate cancer patients following docetaxel chemotherapy are reported. |
Mendeley readers
The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 6 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 1 | 17% |
| Unknown | 5 | 83% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 1 | 17% |
| Unknown | 5 | 83% |